This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sprong, T.
Right arrow Articles by Mollnes, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sprong, T.
Right arrow Articles by Mollnes, T. E.

 Previous Article  |  Next Article 

Infection and Immunity, June 2004, p. 3344-3349, Vol. 72, No. 6
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.6.3344-3349.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide

Tom Sprong,1* Anne-Sophie W. Møller,2 Anna Bjerre,3 Elisabeth Wedege,4 Peter Kierulf,2 Jos W. M. van der Meer,1 Petter Brandtzaeg,3 Marcel van Deuren,1 and T. E. Mollnes5

Department of General Internal Medicine, University Medical Centre St. Radboud Nijmegen, Nijmegen, The Netherlands,1 The R & D Group, Department of Clinical Chemistry,2 Department of Paediatrics, Ullevål University Hospital,3 Norwegian Institute of Public Health,4 Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway5

Received 28 November 2003/ Returned for modification 21 January 2004/ Accepted 19 February 2004

Fulminant meningococcal sepsis has been termed the prototypical lipopolysaccharide (LPS)-mediated gram-negative septic shock. Systemic inflammation by activated complement and cytokines is important in the pathogenesis of this disease. We investigated the involvement of meningococcal LPS in complement activation, complement-dependent inflammatory effects, and cytokine or chemokine production. Whole blood anticoagulated with lepirudin was stimulated with wild-type Neisseria meningitidis H44/76 (LPS+), LPS-deficient N. meningitidis H44/76lpxA (LPS), or purified meningococcal LPS (NmLPS) at concentrations that were relevant to meningococcal sepsis. Complement activation products, chemokines, and cytokines were measured by enzyme-linked immunosorbent assays, and granulocyte CR3 (CD11b/CD18) upregulation and oxidative burst were measured by flow cytometry. The LPS+ and LPS N. meningitidis strains both activated complement effectively and to comparable extents. Purified NmLPS, used at a concentration matched to the amount present in whole bacteria, did not induce any complement activation. Both CR3 upregulation and oxidative burst were also induced, independent of LPS. Interleukin-1ß (IL-1ß), tumor necrosis factor alpha, and macrophage inflammatory protein 1{alpha} production was predominantly dependent on LPS, in contrast to IL-8 production, which was also markedly induced by the LPS meningococci. In this whole blood model of meningococcal sepsis, complement activation and the immediate complement-dependent inflammatory effects of CR3 upregulation and oxidative burst occurred independent of LPS.


* Corresponding author. Mailing address: Department of General Internal Medicine, University Medical Centre St. Radboud Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-243618819. Fax: 31-243541734. E-mail: t.sprong{at}aig.umcn.nl.

Editor: J. N. Weiser


Infection and Immunity, June 2004, p. 3344-3349, Vol. 72, No. 6
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.6.3344-3349.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Plested, J. S., Welsch, J. A., Granoff, D. M. (2009). Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity. CVI 16: 785-791 [Abstract] [Full Text]  
  • Hellerud, B. C., Stenvik, J., Espevik, T., Lambris, J. D., Mollnes, T. E., Brandtzaeg, P. (2008). Stages of Meningococcal Sepsis Simulated In Vitro, with Emphasis on Complement and Toll-Like Receptor Activation. Infect. Immun. 76: 4183-4189 [Abstract] [Full Text]  
  • Salvesen, B., Fung, M., Saugstad, O. D., Mollnes, T. E. (2008). Role of Complement and CD14 in Meconium-Induced Cytokine Formation. Pediatrics 121: e496-e505 [Abstract] [Full Text]  
  • Munford, R. S. (2008). Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?. Infect. Immun. 76: 454-465 [Full Text]  
  • Schultz, H., Hume, J., Zhang, D. S., Gioannini, T. L., Weiss, J. P. (2007). A Novel Role for the Bactericidal/Permeability Increasing Protein in Interactions of Gram-Negative Bacterial Outer Membrane Blebs with Dendritic Cells. J. Immunol. 179: 2477-2484 [Abstract] [Full Text]  
  • Brekke, O.-L., Christiansen, D., Fure, H., Fung, M., Mollnes, T. E. (2007). The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J. Leukoc. Biol. 81: 1404-1413 [Abstract] [Full Text]  
  • Sprong, T., Roos, D., Weemaes, C., Neeleman, C., Geesing, C. L. M., Mollnes, T. E., van Deuren, M. (2006). Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood 107: 4865-4870 [Abstract] [Full Text]  
  • Plant, L., Wan, H., Jonsson, A.-B. (2006). MyD88-Dependent Signaling Affects the Development of Meningococcal Sepsis by Nonlipooligosaccharide Ligands.. Infect. Immun. 74: 3538-3546 [Abstract] [Full Text]  
  • Post, D. M. B., Zhang, D., Eastvold, J. S., Teghanemt, A., Gibson, B. W., Weiss, J. P. (2005). Biochemical and Functional Characterization of Membrane Blebs Purified from Neisseria meningitidis Serogroup B. J. Biol. Chem. 280: 38383-38394 [Abstract] [Full Text]